Nivolumab plus interferon-γ in the treatment of intractable mucormycosis

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	18
Number of pages	1
Journal	The Lancet Infectious Diseases
Volume	17
Issue number	1
DOIs	https://doi.org/10.1016/S1473-3099(16)30541-2
State	Published - Jan 1 2017

Access to Document

@article{e551c6716c124caf930634a2fa1e03a6,

title = "Nivolumab plus interferon-γ in the treatment of intractable mucormycosis",

author = "David Grimaldi and Olivier Pradier and Hotchkiss, \{Richard S.\} and Vincent, \{Jean Louis\}",

year = "2017",

month = jan,

day = "1",

doi = "10.1016/S1473-3099(16)30541-2",

language = "English",

volume = "17",

pages = "18",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

number = "1",

}

TY - JOUR

T1 - Nivolumab plus interferon-γ in the treatment of intractable mucormycosis

AU - Grimaldi, David

AU - Pradier, Olivier

AU - Hotchkiss, Richard S.

AU - Vincent, Jean Louis

PY - 2017/1/1

Y1 - 2017/1/1

UR - https://www.scopus.com/pages/publications/85008154354

U2 - 10.1016/S1473-3099(16)30541-2

DO - 10.1016/S1473-3099(16)30541-2

M3 - Letter

C2 - 27998559

AN - SCOPUS:85008154354

SN - 1473-3099

VL - 17

SP - 18

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 1

ER -